Tag
Alzheimer’s drug
-
Reporters uncover conflicts and dubious data on latest Alzheimer’s drug
A blockbuster story in The BMJ showed major concerns surrounding the approval process, efficacy and safety of the Alzheimer’s drug…
-
What journalists should know before diving into drug investigations
Learn how two investigative journalists uncovered a trove of information about the recently approved Alzheimer’s drug donanemab.
-
Adieu, Aduhelm: Biogen pulls plug on controversial Alzheimer’s drug
The discontinuation of Biogen’s Aduhelm is a cautionary tale of overpromising, under-delivering, and an inside look at FDA sausage-making.
-
Q&A: What to know about new Alzheimer’s drug Leqembi
The FDA granted full clinical approval to Leqembi (lecanemab) on Thursday, July 6, making it only the second new drug…